logo

ORIC

ORIC Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)

ORIC fundamentals

ORIC Pharmaceuticals (ORIC) released its earnings on Nov 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.33 (YoY +32.65%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.33
+32.65%
Report date
Nov 13, 2025

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

ORIC Pharmaceuticals (ORIC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

ORIC Pharmaceuticals (ORIC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

ORIC Pharmaceuticals (ORIC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

ORIC Pharmaceuticals (ORIC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does ORIC Pharmaceuticals (ORIC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track ORIC Pharmaceuticals (ORIC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield